T cell-driven initiation and propagation of autoimmune diabetes

Current Opinion in Immunology

Volumn 23, Issue 6, 2011, Pages 754-760

  Bettini, Maria ^a   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL DESTRUCTION; DIABETES MELLITUS; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE DELETION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MICROENVIRONMENT; MICROFLORA; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PATHOGENICITY; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; HUMANS; INSULIN; T-LYMPHOCYTES;

EID: 82955195629     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.10.002     Document Type: Review

References (50)

1. Bluestone J.A., Herold K., Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464:1293-1300.
2. Atkinson M.A., Leiter E.H. The NOD mouse model of type 1 diabetes: as good as it gets?. Nat Med 1999, 5:601-604.
3. Wong F.S., Hu C., Xiang Y., Wen L. To B or not to B - pathogenic and regulatory B cells in autoimmune diabetes. Curr Opin Immunol 2010, 22:723-731.
4. Lehuen A., Diana J., Zaccone P., Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010, 10:501-513.
5. Andre I., Gonzalez A., Wang B., Katz J., Benoist C., Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A 1996, 93:2260-2263.
6. Filippi C.M., von Herrath M.G. Viral trigger for type 1 diabetes: pros and cons. Diabetes 2008, 57:2863-2871.
7. Nejentsev S., Walker N., Riches D., Egholm M., Todd J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
8. Stadinski B., Kappler J., Eisenbarth G.S. Molecular targeting of islet autoantigens. Immunity 2010, 32:446-456.
9. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., Hu C., Wong F.S., Szot G.L., Bluestone J.A., et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008, 455:1109-1113.
10. Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Novelo L.L., Casella G., Drew J.C., Ilonen J., Knip M., Hyoty H., et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011, 5:82-91.
11. Sapone A., de Magistris L., Pietzak M., Clemente M.G., Tripathi A., Cucca F., Lampis R., Kryszak D., Carteni M., Generoso M., et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006, 55:1443-1449.
12. Vaarala O. The role of the gut in beta-cell autoimmunity and type 1 diabetes: a hypothesis. Pediatr Diabetes 2000, 1:217-225.
13. Turley S.J., Lee J.W., Dutton-Swain N., Mathis D., Benoist C. Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A 2005, 102:17729-17733.
14. + T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes 2011, 60:2120-2124.
15. Martinic M.M., von Herrath M.G. Real-time imaging of the pancreas during development of diabetes. Immunol Rev 2008, 221:200-213.
16. Gagnerault M.C., Luan J.J., Lotton C., Lepault F. Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med 2002, 196:369-377.
17. Rangel-Moreno J., Moyron-Quiroz J.E., Carragher D.M., Kusser K., Hartson L., Moquin A., Randall T.D. Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity 2009, 30:731-743.
18. Zaccone P., Fehervari Z., Jones F.M., Sidobre S., Kronenberg M., Dunne D.W., Cooke A. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003, 33:1439-1449.
19. Raine T., Zaccone P., Mastroeni P., Cooke A. Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes. J Immunol 2006, 177:2224-2233.
20. Kriegel M.A., Sefik E., Hill J.A., Wu H.J., Benoist C., Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A 2011, 108:11548-11553.
21. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., Littman D.R., Benoist C., Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
22. Gray D.H., Gavanescu I., Benoist C., Mathis D. Danger-free autoimmune disease in Aire-deficient mice. Proc Natl Acad Sci U S A 2007, 104:18193-18198.
23. Zhang S., Zhong J., Yang P., Gong F., Wang C.Y. HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes. Int J Clin Exp Pathol 2009, 3:24-38.
24. Green D.R., Ferguson T., Zitvogel L., Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009, 9:353-363.
25. Han J., Zhong J., Wei W., Wang Y., Huang Y., Yang P., Purohit S., Dong Z., Wang M.H., She J.X., et al. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 2008, 57:2118-2127.
26. Lennon G.P., Bettini M., Burton A.R., Vincent E., Arnold P.Y., Santamaria P., Vignali D.A. T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event. Immunity 2009, 31:643-653.
27. + T cell inflammation. Proc Natl Acad Sci U S A 2010, 107:9317-9322.
28. Calderon B., Carrero J.A., Miller M.J., Unanue E.R. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A 2011, 108:1561-1566.
29. Wright G.P., Notley C.A., Xue S.A., Bendle G.M., Holler A., Schumacher T.N., Ehrenstein M.R., Stauss H.J. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc Natl Acad Sci U S A 2009, 106:19078-19083.
30. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
31. Doyle H.A., Mamula M.J. Posttranslational modifications of self-antigens. Ann N Y Acad Sci 2005, 1050:1-9.
32. Sarukhan A., Bedossa P., Garchon H.J., Bach J.F., Carnaud C. Molecular analysis of TCR junctional variability in individual infiltrated islets of non-obese diabetic mice: evidence for the constitution of largely autonomous T cell foci within the same pancreas. Int Immunol 1995, 7:139-146.
33. Bettini M., Szymczak-Workman A.L., Forbes K., Castellaw A.H., Selby M., Pan X., Drake C.G., Korman A.J., Vignali D.A. Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3. J Immunol 2011, 187:3493-3498.
34. Han B., Serra P., Yamanouchi J., Amrani A., Elliott J.F., Dickie P., Dilorenzo T.P., Santamaria P. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 2005, 115:1879-1887.
35. Bettini M., Vignali D.A. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009, 21:612-618.
36. Tang Q., Adams J.Y., Penaranda C., Melli K., Piaggio E., Sgouroudis E., Piccirillo C.A., Salomon B.L., Bluestone J.A. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 2008, 28:687-697.
37. Long S.A., Cerosaletti K., Bollyky P.L., Tatum M., Shilling H., Zhang S., Zhang Z.Y., Pihoker C., Sanda S., Greenbaum C., et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 2010, 59:407-415.
38. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., Gonzalez-Munoz A., Clark J., Veijola R., Cubbon R., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007, 39:329-337.
39. + T reg cells impinge on autoimmune diabetes. J Exp Med 2005, 202:1387-1397.
40. Feuerer M., Shen Y., Littman D.R., Benoist C., Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009, 31:654-664.
41. + T-cells in type 1 diabetes. Diabetes 2005, 54:1407-1414.
42. You S., Belghith M., Cobbold S., Alyanakian M.A., Gouarin C., Barriot S., Garcia C., Waldmann H., Bach J.F., Chatenoud L. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 2005, 54:1415-1422.
43. + regulatory T cells. J Immunol 2008, 181:7350-7355.
44. Vezys V., Masopust D., Kemball C.C., Barber D.L., O'Mara L.A., Larsen C.P., Pearson T.C., Ahmed R., Lukacher A.E. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J Exp Med 2006, 203:2263-2269.
45. Zhao J., Perlman S. De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system. J Immunol 2009, 183:5163-5170.
46. Penaranda C., Tang Q., Ruddle N.H., Bluestone J.A. Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs. Diabetes 2010, 59:1461-1468.
47. Henry R.A., Kendall P.L. CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice. J Immunol 2010, 185:1460-1465.
48. Tian J., Zekzer D., Lu Y., Dang H., Kaufman D.L. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice. J Immunol 2006, 176:2654-2661.
49. + T cells in gut Peyer's patches. Science 2009, 323:1488-1492.
50. Calderon B., Carrero J.A., Miller M.J., Unanue E.R. Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response. Proc Natl Acad Sci U S A 2011, 108:1567-1572.